Skip to main content
Online First
“Chemo Brain” Can Persist for 2 Decades
Read More
Online First
GIST Outside GI Tract Has Poor Prognosis
Read More
Online First
Best Practices in Maximizing Adherence to Cancer Therapy
Lea Ann Hansen, PharmD, BCOP
Read More
Online First
Stakeholder’s Perspective: Nursing
Beth Faiman, PhD, APRN-BC, AOCN
Read More
Online First
Stakeholder’s Perspective: Physician
Jeffrey A. Meyerhardt MD, MPH
Read More
Online First
Stakeholder’s Perspective: Pharmacy
Steven Stricker, PharmD, MS, BCOP
Read More
Online First
Impact of Nonadherence to Cancer Therapy
Lea Ann Hansen, PharmD, BCOP
Read More
Original Research
Tolerability of Carboplatin When Using Rounded Serum Creatinine Values
Daniel J. Bestul, PharmD, BCOP, Amy L. Mazloom, PharmD
Read More
FDA Updates, PARP Inhibitors
A Review of PARP Inhibitors in Clinical Development
Sarah Hopps, PharmD, Carla D. Kurkjian, MD, Shubham Pant, MD
Read More
From the Literature, From the Literature
Bevacizumab Delays Progression in Women with Advanced Ovarian Cancer
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
Page 191 of 200
Results 1901 - 1910 of 1993